Stock listing

Astrazeneca Plc

Selected listing: 886715 · LSX · EUR · DE

Astrazeneca Plc (LS Exchange: 886715), Health Technology. Latest release Oct 6, 2026: AstraZeneca : Alexion to showcase Phase III data in hypophosphatasia…

886715:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: 886715
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Astrazeneca Plc

AstraZeneca : Alexion to showcase Phase III data in hypophosphatasia and hypoparathyroidism at ASBMR 2026 Annual Meeting

October 6, 2026

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts

October 5, 2026

AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics

October 5, 2026

AstraZeneca completes equity investment in Summit

October 5, 2026

Daiichi Sankyo : and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway® in Combination with Ivonescimab Across Multiple Tumor Types

October 2, 2026

All Astrazeneca Plc news →

Events

Replays

AstraZeneca PLC (AZN) Q2 2026 Earnings Call
Mon, Jul 27, 2026 · 06:45 AM ET
Watch
AstraZeneca PLC (AZN) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 09:30 AM ET
Watch
AstraZeneca PLC (AZN) Q4 2025 Earnings Call
Tue, Feb 10, 2026 · 06:45 AM ET
Watch

Research Astrazeneca Plc

Astrazeneca Plc company profile

View the public company page for Astrazeneca Plc on 6ix.

Astrazeneca Plc news

Read company news and market updates connected to Astrazeneca Plc.

Astrazeneca Plc investor events

Find investor webinars, events, and replay context for Astrazeneca Plc.